Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 versus placebo and entacapone in levodopa-treated Parkinson's disease with motor fluctuations
2006-002937-20Phase 3Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2006
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of perampanel in Parkinson's disease (PD) (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Primary efficacy on motor function. Started Oct 2006; status: terminated.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-002937-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002937-20.